As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

Johnson & Johnson (NYSE:JNJ) is reportedly suing Samsung Bioepis for breach of contract related to the launch of a biosimilar ...

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

The Franklin U.S. Low Volatility High Dividend ETF has a portfolio of 111 stocks selected based on yield, price volatility, ...

Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven ...

We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where Johnson ...

A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.

Mizuho analyst Graig Suvannavejh downgraded Intra-Cellular (ITCI) to Neutral from Outperform with a price target of $132, down from $140, ...

Kentucky Retirement Systems Insurance Trust Fund increased its stake in Johnson & Johnson by 40.2%, owning 99,915 shares ...